对HPV治疗疫苗的进展:对人类临床试验的审查
Elena Martín1, Gabriel Reina2,3, Silvia Carlos3,4
1School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain.
Current oncology (Toronto, Ont.)
|November 26, 2025
概括
治疗性人类乳头瘤病毒 (HPV) 疫苗在清除持久感染和治疗癌前宫病变方面表现有前途. 基于DNA的疫苗,如VGX-3100,表现出一致的结果,进入后期试验阶段.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 子宫癌是一个全球性的健康问题,主要是由持续高风险的人类乳头瘤病毒 (HPV) 感染引起的.
- 预防性HPV疫苗可以预防新的感染,但不能治疗现有的感染.
研究的目的:
- 审查治疗性HPV疫苗的临床证据及其在促进病毒清除中的有效性.
- 评估治疗性HPV疫苗开发的进展和挑战.
主要方法:
- 进行了PubMed的文献搜索,以确定关于HPV清除的人类研究.
- 分析了涉及基于DNA,病毒载体,基和细菌载体疫苗的17项临床试验.
主要成果:
- 基于DNA的疫苗,特别是VGX-3100,在促进HPV清除方面显示出最一致的结果.
- 虽然早期的试验面临挑战,但最近的基于DNA的候选人正在通过II/III期试验取得进展.
- 治疗性疫苗引起T细胞反应,可以诱导癌前病变的回归.
结论:
- 治疗性HPV疫苗是一个快速发展的领域,有可能补充现有的宫癌控制策略.
- 需要进一步的标准化试验来确认有效性并促进商业批准.
- 这些疫苗为加强全球宫癌控制提供了希望,特别是在低收入和中等收入国家 (LMICs).
相关概念视频
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...


